$QNTA Subsidiary Medolife Rx is receiving high pra
Post# of 6022
QNTA Update as Medolife Rx Announces Results of Comparative Study of Its Flagship CBD-based Muscle Rub and Competitor Products https://finance.yahoo.com/news/medolife-rx-an...;tsrc=twtr